Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
- 1 June 1993
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 363 (6429) , 515-521
- https://doi.org/10.1038/363515a0
Abstract
Neurofibromatosis type 2 (NF2) is a monogenic dominantly inherited disease predisposing carriers to develop nervous system tumours. To identify the genetic defect, the region between two flanking polymorphic markers on chromosome 22 was cloned and several genes identified. One is the site of germ-line mutations in NF2 patients and of somatic mutations in NF2-related tumours. Its deduced product has homology with proteins at the plasma membrane and cytoskeleton Interface, a previously unknown site of action of tumour suppressor genes in humans.Keywords
This publication has 37 references indexed in Scilit:
- Mapping of human chromosome 22 with a panel of somatic cell hybridsGenomics, 1991
- Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analysesCancer Genetics and Cytogenetics, 1990
- Neurofibromatosis 2New England Journal of Medicine, 1988
- Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.Proceedings of the National Academy of Sciences, 1987
- Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22Nature, 1987
- Molecular genetic approach to human meningioma: loss of genes on chromosome 22.Proceedings of the National Academy of Sciences, 1987
- Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor genePublished by Elsevier ,1987
- Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17Science, 1987
- Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuromaNature, 1986
- Epidemiology of acoustic neuromasThe Journal of Laryngology & Otology, 1984